The clinical stakes are considerable. Gastric cancer remains a leading cause of cancer death worldwide, and its prognosis depends overwhelmingly on the stage at which it is detected. Early gastric cancer, confined to the innermost layers of the stomach wall, can often be treated endoscopically with organ preservation and excellent survival, whereas advanced disease carries a far grimmer outlook. That is why screening and opportunistic upper endoscopy place such emphasis on meticulous inspection. Professional bodies such as the European Society of Gastrointestinal Endoscopy and the Japan Gastroenterological Endoscopy Society have long recognized that incomplete visualization is a major source of missed lesions, and they have promoted systematic inspection protocols that divide the stomach into standard anatomical regions. What has been missing is an automated, quantitative measure of exposure that does not depend on an observer’s subjective judgment of whether a photograph or video frame shows a well-distended, clean, fully visible patch of mucosa.

The research team, led by investigators at Renmin Hospital of Wuhan University together with collaborator Cesare Hassan of Humanitas University in Milan, set out to close that gap. Their approach rests on a deep convolutional neural network trained to perform semantic segmentation of endoscopic images, meaning the model learns to classify every pixel in a frame as belonging to visible gastric mucosa or not. Before training and validating the algorithm, a panel of expert endoscopists defined a reference standard covering 19 anatomical sites of the stomach, spanning the greater and lesser curvatures and the anterior and posterior walls of the gastric body and antrum, along with the cardia, fundus, and angularis. For each of these sites, the experts established a threshold of mucosal exposure that constitutes adequate visualization. When the algorithm’s measured exposure area for a given site exceeds that threshold, the site is classified as adequately exposed; when it falls short, the site is flagged as inadequately exposed.

Technical validation of the segmentation model was carried out using standard metrics for image segmentation performance, including the mean intersection over union, a measure of how closely the algorithm’s pixel-level delineation of mucosa matches expert annotation. But the true test of the OGMEA concept came from clinical data of unusual scale and rigor. Rather than relying on retrospectively collected endoscopy images, the team embedded their analysis within a randomized controlled trial involving 25,320 participants recruited across 24 centers. This multi-center dataset, gathered under a protocol approved by the ethics committee of Renmin Hospital of Wuhan University and the ethics boards of every participating site, with written informed consent from all participants, provided a large, prospectively collected, and heterogeneous body of examinations against which the association between mucosal exposure and lesion detection could be tested.

The results of that analysis are striking. When the researchers classified assessed anatomical sites by the algorithm’s verdict, they found that only 46.36 percent of sites were adequately exposed, while a slight majority, 53.64 percent, fell below the OGMEA threshold. In other words, even in the setting of a controlled trial, more than half of the stomach regions examined were not visualized to the standard defined by the expert panel. This single number is likely to provoke discussion in endoscopy units around the world, because it quantifies, for the first time at this scale, how much room for improvement exists in a procedure that many patients assume is exhaustive.

More important than the raw exposure figures is what they predicted. At the level of individual anatomical sites, the detection rates of early gastric cancer, gastric neoplasms, precancerous conditions, and focal lesions were all significantly higher in adequately exposed sites than in inadequately exposed ones, with differences reaching statistical significance at the level of P less than 0.001. When the analysis moved to the patient level, the pattern held with remarkable consistency: the number of adequately exposed sites per examination correlated positively with lesion detection across every lesion category, with correlation coefficients ranging from 0.830 to 1.000 and all comparisons significant at P less than 0.01. The message is intuitive but now empirically grounded: the more of the stomach lining an endoscopist shows the camera, the more likely the examination is to yield a clinically meaningful finding.

Because simple correlations can be confounded, the investigators went further, applying multivariable logistic regression using generalized estimating equation models that account for clustering of patients within centers. These adjusted models controlled for whether the participant had been allocated to the intervention or control arm of the original trial, the number of standard anatomical sites screened, and the total inspection time. Even after these adjustments, each additional adequately exposed site was associated with higher odds of detecting early gastric cancer, with an adjusted odds ratio of 1.081 and a 95 percent confidence interval of 1.021 to 1.146, statistically significant at P equal to 0.008. The same held for precancerous conditions, with an adjusted odds ratio of 1.056, and for focal lesions, with an adjusted odds ratio of 1.059. For neoplastic lesions overall, the association pointed in the same direction but narrowly missed conventional statistical significance, with an adjusted odds ratio of 1.038 and a P value of 0.060. Sensitivity analyses clustered by individual endoscopist produced materially consistent estimates, strengthening the case that the effect is not an artifact of a few unusually thorough or unusually lax operators.

What makes the OGMEA system potentially transformative is its fit with the existing trajectory of endoscopy quality assurance. Quality indicators have already reshaped colonoscopy, where measures such as adenoma detection rates and cecal intubation rates are now standard benchmarks for training, credentialing, and pay-for-performance programs. Upper gastrointestinal endoscopy has lagged behind, partly because the stomach’s complex, cavernous anatomy makes exposure harder to standardize and partly because no practical tool existed to measure it in real time or in retrospect. The abbreviations that pepper the study, from CCMEA, the cumulative colorectal mucosal exposure area, to GRACE, the gastroscopy rate of cleanliness evaluation, trace the field’s growing effort to borrow quantitative rigor from its lower-gastrointestinal counterpart. An automated measure of gastric exposure, computed by a neural network from the very video stream the endoscope already produces, could be integrated into endoscopy reporting software without adding any burden to the procedure itself, giving departments a continuous, objective feed of quality data.

The study also illustrates a broader shift in how artificial intelligence is being deployed in medicine. Much of the public conversation about AI in endoscopy has centered on computer-aided detection, in which algorithms highlight polyps or suspicious lesions directly. The OGMEA work takes a complementary path: rather than finding the lesion, the algorithm measures whether the human operator created the conditions under which a lesion could be found. This framing sidesteps some of the regulatory and medicolegal complexities of autonomous diagnosis while still harnessing deep learning to improve outcomes. It also generates actionable feedback for trainees, who can see precisely which of the 19 anatomical sites they tend to under-visualize, whether that is the posterior wall of the fundus or the lesser curvature of the antrum, and adjust their technique accordingly.

Cautions remain, as they should with any new quality metric. The exposure thresholds were defined by expert consensus, and different panels might draw the line between adequate and inadequate visualization somewhat differently. The association between exposure and detection, even in adjusted models, is observational in nature; a randomized trial in which endoscopists are compelled to reach OGMEA targets would be needed to prove that raising exposure causally reduces missed cancers. The modest magnitude of the per-site effect, an odds ratio just above 1, accumulates meaningfully only across many sites, which is precisely how endoscopy works in practice but means the metric is best viewed as one component of a broader quality framework rather than a standalone guarantee. Still, with data from more than 25,000 participants across two dozen centers, consistent results at both site and patient levels, and robustness in sensitivity analyses, the OGMEA study makes a compelling case that the stomach’s hidden surfaces deserve to be counted, and that a neural network watching the monitor may soon help ensure that no corner of the gastric mucosa goes unseen.

Subject of Research: Artificial intelligence-based assessment of gastric mucosal exposure during endoscopy and its association with gastric lesion detection

Article Title: Artificial intelligence-based assessment of gastric mucosal exposure and its association with lesion detection: a multicenter study

Article References: Du, H., Chen, Z., Li, J., Zhang, X., Zu, Q., Zeng, Z., Dong, Z., Hassan, C., Yu, H., & Wan, X. (2026). Artificial intelligence-based assessment of gastric mucosal exposure and its association with lesion detection: a multicenter study. BMC Medicine. https://doi.org/10.1186/s12916-026-05288-8

Image Credits: AI Generated

DOI: 10.1186/s12916-026-05288-8

Keywords: artificial intelligence, endoscopy, gastric cancer, mucosal exposure, quality indicators, deep learning, early detection, gastroenterology, precancerous lesions, multicenter study, screening, Artificial